BARCLAYS PLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,778
+88.5%
521,922
+176.1%
0.00%
+100.0%
Q2 2023$3,065
+1.8%
189,009
+4.5%
0.00%
+100.0%
Q1 2023$3,012
+739.0%
180,879
+373.3%
0.00%
Q4 2022$359
-96.7%
38,215
+847.1%
0.00%
Q3 2022$11,0004,035
+403400.0%
0.00%
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q1 2022$35,000
-95.4%
11,430
-93.1%
0.00%
Q4 2021$764,000
+324.4%
166,064
+482.3%
0.00%
Q3 2021$180,000
+215.8%
28,517
+199.7%
0.00%
Q2 2021$57,000
-89.0%
9,514
-88.4%
0.00%
Q1 2021$517,000
+70.6%
81,797
+51.9%
0.00%
Q4 2020$303,000
-29.5%
53,845
-27.2%
0.00%
Q3 2020$430,000
-49.4%
73,990
-37.3%
0.00%
-100.0%
Q2 2020$850,000
+136.8%
117,941
+53.4%
0.00%
Q1 2020$359,000
-43.5%
76,906
-2.9%
0.00%
Q4 2019$635,000
+171.4%
79,193
+132.8%
0.00%
Q3 2019$234,000
-54.9%
34,020
-45.6%
0.00%
Q2 2019$519,000
+201.7%
62,529
+262.2%
0.00%
Q1 2019$172,000
+93.3%
17,265
+48.2%
0.00%
Q4 2018$89,000
-98.8%
11,647
-97.3%
0.00%
-100.0%
Q3 2018$7,438,000
+228.1%
426,929
+78.7%
0.01%
+150.0%
Q2 2018$2,267,000
+3442.2%
238,953
+1528.5%
0.00%
Q1 2018$64,000
+814.3%
14,673
+770.8%
0.00%
Q4 2017$7,0001,6850.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders